Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study

Changing Concepts: Menopausal Hormone Therapy and Breast Cancer

(2012) R. T. Chlebowski et al.   JNCI-Journal of the National Cancer Institute

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial

(2012) Garnet L Anderson et al.   LANCET ONCOLOGY

Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor-Positive and -Negative Breast Cancer: a Nested Case-Control Study

(2011) R. E. James et al.   Cancer Prevention Research

Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy

(2011) Andrea Z. LaCroix   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy

(2011) V. Beral et al.   JNCI-Journal of the National Cancer Institute

The Influence of Time From Menopause and Mammography on Hormone Therapy-Related Breast Cancer Risk Assessment

(2011) R. T. Chlebowski et al.   JNCI-Journal of the National Cancer Institute

Personalized estimates of breast cancer risk in clinical practice and public health

(2011) Mitchell H. Gail   STATISTICS IN MEDICINE

Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer

(2010) Kerryn W. Reding et al.   BREAST CANCER RESEARCH AND TREATMENT

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

(2010) Rowan T. Chlebowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009

(2010) Sandra A. Tsai et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Estrogen-Progestagen Menopausal Hormone Therapy and Breast Cancer: Does Delay From Menopause Onset to Treatment Initiation Influence Risks?

(2009) Agnès Fournier et al.   JOURNAL OF CLINICAL ONCOLOGY

Recent Changes in Breast Cancer Incidence in Spain, 1980–2004

(2009) Marina Pollán et al.   JNCI-Journal of the National Cancer Institute

Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal Women

(2008) R. L. Prentice et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Improved breast cancer survival among hormone replacement therapy users is durable after 5 years of additional follow-up

(2008) Dara Christante et al.   AMERICAN JOURNAL OF SURGERY

Estrogen Plus Progestin and Breast Cancer Detection by Means of Mammography and Breast Biopsy

(2008) Rowan T. Chlebowski   ARCHIVES OF INTERNAL MEDICINE

Prediagnostic Use of Hormone Therapy and Mortality After Breast Cancer

(2008) P. A. Newcomb et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prognostic Role of Detection Method and Its Relationship with Tumor Biomarkers in Breast Cancer: The University of Texas M. D. Anderson Cancer Center Experience

(2008) W. Dong et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of Screening

(2008) H. Sihto et al.   CLINICAL CANCER RESEARCH

The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy

(2008) A. Gompel et al.   MATURITAS